Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Molybdenum-dependent enzymes, also known as molybdoenzymes, are a diverse group of enzymes that require the trace element molybdenum (Mo) as an essential cofactor for their catalytic activity. These enzymes are found across all domains of life and play critical roles in key biological processes, particularly in the global cycles of carbon, nitrogen, and sulfur. The active site of most molybdoenzymes contains a unique prosthetic group called the molybdenum cofactor (Moco), which consists of a molybdenum atom coordinated by one or two organic molecules known as pyranopterin or molybdopterin. In humans, four well-characterized molybdoenzymes exist: Sulfite oxidase, Xanthine oxidoreductase (includes xanthine dehydrogenase/oxidase), Aldehyde oxidase, and Mitochondrial amidoxime reducing component (mARC). These catalyze reactions such as oxidation/reduction involving small molecules—e.g., conversion of sulfite to sulfate or xanthine to uric acid.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Molybdenum-Dependent Enzyme (Molybdoenzyme).